| Literature DB >> 20660656 |
Benjamin L Prosser1, Christopher W Ward, W J Lederer.
Abstract
Entities:
Mesh:
Substances:
Year: 2010 PMID: 20660656 PMCID: PMC2912070 DOI: 10.1085/jgp.201010406
Source DB: PubMed Journal: J Gen Physiol ISSN: 0022-1295 Impact factor: 4.086
Figure 1.RYR2s in cardiac ventricular myocytes. (A) Diagram of heart cell illustrating the locations of the TTs and SL with respect to the L-type Ca2+ channels (LCC), the junctional SR (jSR), the longitudinal SR, SERCA, RYR2 cluster, subspace, the Na+/Ca2+ exchanger (NCX), the plasmalemmal Ca2+ ATPase (PMCA), and a mitochondrion. (B) The dashed box (in A) is enlarged to reveal some of the changes that may occur in DMD. Micro-ruptures may lead to an increase in [Ca2+]i and [Na+]i, as may hyperactivity of stretch-activated channels (SAC); overexpression of caveoli, a putative site of NADPH oxidase, may also be involved. (C) Diagrammatic illustration how PoRYR2 sensitivity to [Ca2+]i may be shifted to A (increase in sensitivity) or shifted to B (decrease in sensitivity). See Table I.
Changes in the sensitivity of RYR2 to be opened by [Ca2+]i
| A—Increase in RYR2 sensitivity | B—Decrease in RYR2 sensitivity |
| Increased [Ca2+]SR | Decreased [Ca2+]SR |
| ( | ( |
| RYR2 phosphorylation at PKA or CaMKII sites | Calstabin2 (FKBP 12.6) binding |
| ( | ( |
| Caffeine | Tetracaine |
| ( | ( |
| RYR2 oxidation (ROS) | Anti-oxidation |
| ( | ( |
| RYR2 CPVT mutations | |
| ( | |
| Calsequestrin mutations | |
| ( | |
| Triadin | |
| ( | |
| RYR2 nitrosylation | |
| ( |